Zhou Ming-Ming MM

Show results for

Unknown (45)
Transcriptomics (6)
Metabolomics (4)
Proteomics (4)

Organisms

Andropogon gerardi (4)
Bacteria (4)
Borrelia (4)
Botrytis cinerea (4)
Candida albicans (4)
Canis lupus familiaris (4)
Clostridium perfringens (4)
Cnidaria (4)
Eukaryota (4)
Fasciola (4)
Fungi (4)
Hepatitis B virus (4)
Human betaherpesvirus 5 (4)
Influenza C virus (4)
Japanese encephalitis virus group (4)
Miscanthus x giganteus (4)
Mycobacterium tuberculosis (4)
Orthoflavivirus (4)
Panicum virgatum (4)
Platyhelminthes (4)
Pseudomonas aeruginosa AES-1R (4)
Rickettsia (4)
Saccharomyces cerevisiae (4)
Schizosaccharomyces pombe (4)
Severe acute respiratory syndrome coronavirus 2 (4)
Sorghastrum nutans (4)
Homo sapiens (3)
Oryza sativa Japonica Group (1)
Rattus norvegicus (1)
Mus musculus (1)

Repository

biostudies-arrayexpress (6)
MetaboLights (4)
pride (4)

Tissue

Cell culture (2)
Epithelial cell (1)
Melanocyte (1)
Regulation of gastric acid secretion (1)
Sciatic nerve (1)

Disease

Normal (1)
Breast cancer (1)
Diffuse gastric cancer (1)

Technology Type

Mass Spectrometry (4)
Mass spectrometry (3)
Shotgun proteomics (2)
NMR spectroscopy (1)
Bottom-up proteomics (1)
Gel-based experiment (1)

Instrument Platform

ScanArray Express HT [PerkinElmer] (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Gas Chromatography MS - positive (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2015 (2)
2008 (2)
2025 (2)
2023 (2)
2022 (2)
2006 (1)
2005 (1)
2021 (1)
2020 (1)

CHEBI ID

CHEBI:132295 (2)
CHEBI:88817 (2)
CHEBI:23012 (2)
CHEBI:77509 (2)
CHEBI:4614 (2)
CHEBI:16182 (2)
CHEBI:27750 (2)
CHEBI:78002 (2)
CHEBI:39932 (2)
CHEBI:80945 (2)
CHEBI:89197 (2)
CHEBI:87510 (2)
CHEBI:16716 (2)
CHEBI:17935 (2)
CHEBI:41330 (2)
CHEBI:28903 (2)
CHEBI:87393 (2)
CHEBI:35986 (2)
CHEBI:77417 (2)
CHEBI:89871 (2)
CHEBI:16101 (2)
CHEBI:34787 (2)
CHEBI:45296 (2)
CHEBI:84268 (2)
CHEBI:88528 (2)
CHEBI:49000 (2)
CHEBI:16310 (2)
CHEBI:61748 (2)
CHEBI:17169 (2)
CHEBI:16424 (2)

Metabolite Name

1-Decanol (2)
3-Octanol (2)
Heptasiloxane, hexadecamethyl- (2)
Acetic acid, hexyl ester (2)
2,2,4-Trimethyl-1,3-pentanediol diisobutyrate (2)
3-Phenylpropanol (2)
1-Tetradecanol (2)
2-Octenal, (E)- (2)
Carbon disulfide (2)
Heptane, 2,2,4,6,6-pentamethyl- (2)
Furan, 2-pentyl- (2)
Butanal, 2-methyl- (2)
Ethyl Acetate (2)
Phenylethyl Alcohol (2)
1-Octen-3-ol (2)
1-Hexanol (2)
Dodecane (2)
Disiloxane, hexamethyl- (2)
Tributyl phosphate (2)
1-Nonanol (2)
Pentadecane (2)
Heptanal (2)
Hexanal (2)
Nonanal (2)
Hexadecane (2)
Eucalyptol (2)
Octanal (2)
Ethylbenzene (2)
Benzaldehyde (2)
Hexanoic acid (2)

Study type

Transcription profiling by array (5)
Transcription profiling by SAGE (1)

Release Date

2023 (8)
2025 (6)
2018 (5)
2021 (4)
2017 (4)
2015 (3)
2024 (3)
2022 (3)
2020 (3)
2016 (3)
2014 (3)
2008 (2)
2006 (1)
2005 (1)
2019 (1)
2012 (1)

Lab affiliation

Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China. (1)
Department of Toxicology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China tel:17534997727 (1)
Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. (1)
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University,Guangzhou 510515, P.R.China (1)

Previous page
1 / 6
You're on page 1
page 2
page 3
page 4
page 5
page 6
Next page

Sort by:

Relevance

Page size

LC-MS data of IM95 gastric cancer cells following YAP degradation by bioPROTAC

In this study, through naïve nanobody phage library screening, we have identified multiple nanobodies against human YAP with high affinity and specificity. The YAP nanobody was then fused to the RING domain of RNF4, creating a bio-Proteolysis-Targeting Chimera (bioPROTAC) molecule capable of selecti...

ORGANISM(S): Homo sapiens (Human)

2025-11-03 | PXD063726 | Pride

Bromodomain biology and drug discovery.

Not available

S-EPMC6984398 | biostudies-literature

Auxin regulated metabolic changes underlying sepal retention and development after pollination in spinach.

Not available

S-EPMC8022616 | biostudies-literature

Targeting lysine acetylation readers and writers.

Not available

S-EPMC11798720 | biostudies-literature

Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling.

Not available

S-EPMC8553370 | biostudies-literature

Could PROTACs Protect Us From COVID-19?

Not available

S-EPMC7462587 | biostudies-literature

Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk

Dysregulated extravillous trophoblast invasion and proliferation are known to increase the risk of recurrent spontaneous abortion (RSA); however, the underlying mechanism remains unclear. Herein, in our retrospective observational case-control study we show that villous samples from RSA patients, co...

2021-10-06 | MTBLS2148 | MetaboLights

Bromodomain inhibitors and therapeutic applications.

Not available

S-EPMC10524616 | biostudies-literature

Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Not available

S-EPMC5581715 | biostudies-literature

Privileged diazepine compounds and their emergence as bromodomain inhibitors.

Not available

S-EPMC4035449 | biostudies-literature